Latest AI and machine learning research in depression for healthcare professionals.
Postpartum depression (PPD) affects 10–15% of mothers annually, yet early identification remains challenging. We introduce ClinPreAI, a novel agentic AI system that autonomously designs, implements, and evaluates machine learning solutions for PPD risk prediction using multimodal electronic health record data. We analyzed data from 4,161 pregnant individuals at Texas Children’s Hospital (2012–2025...
Arachnoiditis, a painful and potentially disabling neurological condition, results from persistent inflammation of the spinal cord pia-arachnoid membranes following injury. While considered rare, the condition is underdiagnosed. Research on symptomatology, diagnosis, and treatments is scarce, hindering clinical management. Artificial intelligence (AI) offers promising opportunities for rare diseas...
Personalized data-driven interventions for depression are much needed. Here, we leveraged N-of-1 machine learning (ML) to optimally target behavioral ...
Medication use during adolescence provides important insight into current health and treatment patterns. However, these data are often difficult to an...
Major depressive disorder (MDD) with suicidality represents a significant public health concern, as suicide ranks among the leading causes of death wo...
Living with multiple long-term conditions (MLTC) profoundly impacts patients’ lives, affecting not only their health but also their financial, emotion...
Perinatal depression affects up to 30% of pregnant and postpartum women, which has increased since the COVID-19 pandemic, making rapidly identifying a...
Schizophrenia (SCZ) is associated with widespread gray matter volume (GMV) reductions, yet the underlying mechanisms driving these alterations remain ...
Artificial Intelligence (AI) voice applications have the potential to address the unmet treatment needs among patients with depression and anxiety, bu...
Depression is a leading cause of global disability. Timely identification of patients at risk for clinical worsening remains a major challenge. Electr...
This study introduces a novel transformer-based ensemble framework for the multi-label detection of mental health disorders from social media posts. U...
Major depressive disorder (MDD) affects millions worldwide, yet its neurobiological underpinnings remain elusive. Neuroimaging studies have yielded in...
Antidepressant use is common in people with dementia. Antidepressants may be started to manage symptoms of dementia, rather than depressive and anxiet...
Major depressive disorder (MDD) is a neuro-immune, oxidative, and nitrosative stress (NIMETOX) disorder, in which peripheral immune-redox pathways int...
Estrogen fluctuations have been implicated in various mood disorders, including perimenopausal and postpartum depression (PPD), likely through complex...
This study aimed to predict suicidal ideation among youth with autism spectrum disorder (ASD) by applying machine learning techniques. A cross-section...
Differentiating psychopathologies is challenging due to shared underlying mechanisms, such as the -factor. Nevertheless, recent methodological advanc...
BACKGROUND: Depression is major global public health problems among university students. Currently, the evaluation and monitoring of depression predom...
CONTEXT AND BACKGROUND: Depression has affected millions of people worldwide and has become one of the most common mental disorders. Early mental diso...
Depression presents a significant challenge to global mental health, often intertwined with factors including oxidative stress. Although the precise r...